Terms: = Ovarian cancer AND ETV6, TEL/ABL, 2120, ENSG00000139083, P41212, TEL AND Diagnosis
5 results:
1. Germline BRCA variants, lifestyle and ovarian cancer survival.
Gersekowski K; Delahunty R; Alsop K; Goode EL; Cunningham JM; Winham SJ; Pharoah P; Song H; Jordan S; Fereday S; DeFazio A; Friedlander M; Obermair A; ; ; Webb PM
Gynecol Oncol; 2022 Jun; 165(3):437-445. PubMed ID: 35400525
[TBL] [Abstract] [Full Text] [Related]
2. How challenging could be preoperative and intraoperative diagnosis of endometrial cancer?
Ferrero A; Attianese D; Villa M; Ravarino N; Menato G; Volpi E
Minerva Obstet Gynecol; 2023 Aug; 75(4):365-370. PubMed ID: 35191637
[TBL] [Abstract] [Full Text] [Related]
3. BRCA mutation status and determinant of outcome in women with recurrent epithelial ovarian cancer treated with pegylated liposomal doxorubicin.
Safra T; Borgato L; Nicoletto MO; Rolnitzky L; Pelles-Avraham S; Geva R; Donach ME; Curtin J; Novetsky A; Grenader T; Lai WC; Gabizon A; Boyd L; Muggia F
Mol Cancer Ther; 2011 Oct; 10(10):2000-7. PubMed ID: 21835933
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathologic characteristics and prognostic factors of ovarian fibrosarcoma: the results of a multi-center retrospective study.
Huang L; Liao LM; Wang HY; Zheng M
BMC Cancer; 2010 Oct; 10():585. PubMed ID: 20979607
[TBL] [Abstract] [Full Text] [Related]
5. Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?
Slomovitz BM; Sun CC; Ramirez PT; Bodurka DC; Diaz P; Lu KH
Obstet Gynecol; 2004 Aug; 104(2):255-60. PubMed ID: 15291996
[TBL] [Abstract] [Full Text] [Related]
